scholarly journals Nursing students' attitudes, knowledge, and willingness to receive the COVID-19 vaccine: A cross-sectional study

2021 ◽  
Author(s):  
Ning Jiang ◽  
Baojian Wei ◽  
Hua Lin ◽  
Youjuan Wang ◽  
Shouxia Chai ◽  
...  
Keyword(s):  
Nursing Students ◽  
Side Effects ◽  
Influencing Factors ◽  
Family Members ◽  
Cross Sectional Survey ◽  
School Students ◽  
Cross Sectional ◽  
Vaccine Acceptance ◽  
Academic Background ◽  
To Receive

Aim: To investigate nursing students' konwledge, attitudes and willingness to receive the COVID-19 vaccine, and the influencing factors. Background: Vaccination is one of the effective measures to prevent COVID-19, but the vaccination acceptance varies across countries and populations. As reserve nurses, nursing students have both the professionalism of medical personnel and the special characteristics of school students, their attitudes, knowledge, and willingness to receive the COVID-19 vaccine may greatly affect the vaccine acceptance of the population now and in the future. But little research has been done on vaccine acceptance among nursing students. Design: A cross-sectional survey of nursing students was conducted via online questionnaires in March 2021. Methods: Descriptive statistics, independent sample t tests/one-way ANOVA (normal distribution), Mann-Whitney U tests/Kruskal-Wallis H tests (skewness distribution) and multivariate linear regression were performed. Results: The score rate of attitude, knowledge and vaccination willingness were 70.07%, 80.70% and 84.38% respectively. Attitude was significantly influenced by family economic conditions and whether a family member had been vaccinated. The main factors influencing knowledge were gender, grade and academic background. In terms of willingness, gender, academic background, visits to risk areas, whether family members were vaccinated, and whether they had side effects were significant influencing factors. Conclusions: The vaccine acceptance of nursing students was fair. Greater focus needed to be placed on the males, those of younger age, with a science background, and having low grades, as well as on students whose family members had not received the COVID-19 vaccine or had side effects from the vaccine. Targeted intervention strategies were recommended to improve vaccination rates.

scholarly journals 1172. SARS-CoV-2 Vaccine Hesitancy in Caregivers of Hospitalized Children

2021 ◽  
Vol 8 (Supplement_1) ◽  
pp. S677-S677
Author(s):  
Marisa Orbea ◽  
Rachel Cunningham ◽  
C Mary Healy ◽  
Julie A Boom ◽  
Claire Bocchini
Keyword(s):  
Vaccine Uptake ◽  
Vaccine Hesitancy ◽  
Hospitalized Children ◽  
Parent Attitudes ◽  
Cross Sectional Survey ◽  
Cross Sectional ◽  
Vaccine Acceptance ◽  
And Behaviors ◽  
Childhood Vaccines ◽  
To Receive

Abstract Background SARS-CoV-2 vaccine hesitancy (VH) is hindering nationwide vaccination efforts; little is known about caregiver SARS-CoV-2 vaccine acceptance for children. We aimed to identify associations with SARS-CoV-2 VH in caregivers of hospitalized children. Methods We conducted a prospective cross-sectional survey in English and Spanish of caregiver COVID-19 knowledge, attitudes, behaviors, and associated VH among hospitalized children 6 months - 18 years at a large pediatric medical institution. Parents were approached daily, averaging 4-5 days/week, from 12/8/2020--4/5/2021. VH was assessed using the Parent Attitudes about Childhood Vaccines (PACV) survey; PACV score ≥50 denoted VH. Descriptive statistics and multivariable logistic regression were used. Responses were categorized. Results 295/307 (96%) of approached caregivers enrolled; 79% were ≥ 30 years, 68% were married/ living with a partner, and 57% had at least some college. 36% identified as white, 19% Black, and 46% Hispanic/ Latino. 53% of caregiver children had public insurance. 91% of caregivers self-reported their children were up to date with routine vaccines. 17% of caregivers were vaccine-hesitant overall. 50% of caregivers were willing to receive COVID-19 vaccine themselves. Figure 1 shows intention to vaccinate their child by PACV score. 65% knew someone who was hospitalized for COVID-19. 67% were scared of their child getting COVID-19. However, 49% were scared of their child getting the vaccine, 28% did not want to vaccinate their child and 27% were neutral in the intention to vaccinate their child. Caregivers who did not intend to vaccinate their child were more likely to be Black (27% vs. 16%, p=0.04) and less likely to be Hispanic/ Latino (33% vs. 49%, p=0.02). Table 1 shows attitudes, beliefs, and behaviors surrounding the COVID-19 pandemic and vaccine in caregivers who did or did not intend to vaccinate their child. Figure 1 COVID-19 vaccine uptake by PACV score Table 1 Caregiver attitudes, beliefs, and behaviors surrounding the COVID-19 pandemic and the COVID-19 vaccine Conclusion The majority of caregivers believe that SARS-CoV-2 vaccine will help control the pandemic, but less than half plan to vaccinate their children. A quarter of caregivers expressed uncertainty regarding the vaccine and therefore may be amenable to education and discussion. COVID-19 VH is different from VH towards routine vaccinations. More research is needed to address COVID-19 specific VH. Disclosures C. Mary Healy, MD, Dexcom (Shareholder)Intuitive (Shareholder)Quidel Corporation (Shareholder)Up to Date (Other Financial or Material Support, Honorarium)Vapotherm (Shareholder)

Burden of Visits for Treating Side Effects of Chemotherapy or Radiotherapy in Cancer Patients.

Blood ◽  
2006 ◽  
Vol 108 (11) ◽  
pp. 5518-5518
Author(s):  
David H. Henry ◽  
Shawn M. Wade ◽  
Mariana Servin ◽  
William Hershfield
Keyword(s):  
Side Effects ◽  
Healthcare Professional ◽  
Cancer Patients ◽  
Full Time ◽  
Cross Sectional Survey ◽  
Cross Sectional ◽  
Part Time ◽  
Receive Treatment ◽  
Doctor's Office ◽  
To Receive

Abstract INTRODUCTION: The time incurred in seeking care for the treatment of side effects of chemotherapy (CT) or radiotherapy (RT) can result in lost productivity and resulting lost wages for cancer patients (pts) and their caregivers. The purpose of this study was to assess the amount of time spent by pts and caregivers to seek treatment for side effects of CT/RT and to examine productivity losses associated with such visits. METHODS: A cross-sectional survey was conducted from April to May 2006 using a random sample of pts from a chronic illness panel of 550,233 pts. Inclusion criteria were being at least 18 years of age, diagnosed with cancer, and receiving CT and/or RT either currently or during the 12 months prior to participating in the study. Percentages and means were used to calculate descriptive statistics. RESULTS: A total of 1,569 cancer pts were surveyed: 1,302 pts online and 267 pts by telephone. No significant differences were found between phone and online respondents. Of the pts currently receiving CT and/or RT (N=814), a total of 249 pts received treatment for side effects of CT/RT. The total time spent per visit to receive treatment for side-effects of CT/RT was approximately 5 hrs/visit including preparation time, travel time, and time spent at the clinic. Approximately one-half (54%) of the 249 patients currently receiving treatment for side effects of CT/RT were employed full-time (44%) or part-time (10%). Among employed patients currently receiving treatment for side effects of CT/RT, the mean number of work days missed as a result of visits for the treatment of CT/RT related side effects was 20 days per year. The primary reason for continuing to work during cancer treatment was financial need, reported by 59% of patients. Approximately 83% of all patients indicated that a caregiver generally accompanied them on their visits to the doctor’s office, clinic, or hospital to receive treatment for side effects of CT/RT. Seven out of ten caregivers (68%) were reported as being employed either full-time (62%) or part-time (6%). CONCLUSIONS: Time related burden for patients receiving treatment for side effects of CT/RT and their caregivers is significant. Reduction in frequency of such visits is important from the standpoint of patients’ economic livelihood and can stand to benefit employers and society. Table 1. Time Spent on Healthcare Provider Visits for Treatment of Side Effects Related to Chemotherapy and/or Radiation (N=249) Activity (per visit) Minutes Spent (mean) Standard Deviation Minutes Spent (median) Preparing to go to the doctor’s office, clinic or hospital 81 127 55 Travel to and from the doctor’s office, clinic, or hospital 102 188 58 Waiting at the doctor’s office, clinic, or hospital to see the doctor or another healthcare professional 64 72 39 Seeing the doctor or another healthcare professional 64 75 43 Total 311 380 210

scholarly journals Corowa-kun: Impact of a COVID-19 vaccine information chatbot on vaccine hesitancy, Japan 2021

2021 ◽  
Author(s):  
Takaaki Kobayashi ◽  
Yuka Nishina ◽  
Hana Tomoi ◽  
Ko Harada ◽  
Kyuto Tanaka ◽  
...  
Keyword(s):  
Vaccine Hesitancy ◽  
Cross Sectional Survey ◽  
Confidential Interval ◽  
Cross Sectional ◽  
Vaccine Acceptance ◽  
Factors Associated ◽  
History Of ◽  
Flu Vaccine ◽  
Vaccine Information ◽  
To Receive

Background: Few studies have assessed how mobile messenger apps affect COVID-19 vaccine hesitancy. We created a COVID-19 vaccine information chatbot in a popular messenger app in Japan to answer commonly asked questions. Methods: LINE is the most popular messenger app in Japan. Corowa-kun, a free chatbot, was created in LINE on February 6, 2021. Corowa-kun provides instant, automated answers to frequently asked COVID-19 vaccine questions. In addition, a cross-sectional survey assessing COVID-19 vaccine hesitancy was conducted via Corowa-kun during April 5 to 12, 2021. Results: A total of 59,676 persons used Corowa-kun during February to April 2021. Of them, 10,192 users (17%) participated in the survey. Median age was 55 years (range 16 to 97), and most were female (74%). Intention to receive a COVID-19 vaccine increased from 59% to 80% after using Corowa-kun (p < 0.01). Overall, 20% remained hesitant: 16% (1,675) were unsure, and 4% (364) did not intend to be vaccinated. Factors associated with vaccine hesitancy were: age 16 to 34 (odds ratio [OR] = 3.7, 95% confidential interval [CI]: 3.0-4.6, compared to age ≥ 65), female sex (OR = 2.4, Cl: 2.1-2.8), and history of another vaccine side-effect (OR = 2.5, Cl: 2.2-2.9). Being a physician (OR = 0.2, Cl: 0.1-0.4) and having received a flu vaccine the prior season (OR = 0.4, Cl: 0.3-0.4) were protective. Conclusions: Corowa-kun reduced vaccine hesitancy by providing COVID-19 vaccine information in a messenger app. Mobile messenger apps could be leveraged to increase COVID-19 vaccine acceptance.

scholarly journals P14.36 Treatment patterns by O6-methylguanine DNA methyltransferase promoter (MGMT) status in newly-diagnosed glioblastoma multiforme (GBM): a multi-country chart review study

2019 ◽  
Vol 21 (Supplement_3) ◽  
pp. iii75-iii75
Author(s):  
A Z Fu ◽  
G J Thompson ◽  
J P Hall ◽  
A Bailey ◽  
J Kemp ◽  
...  
Keyword(s):  
Drug Therapy ◽  
Side Effects ◽  
Dna Methyltransferase ◽  
Treatment Patterns ◽  
Newly Diagnosed ◽  
Cross Sectional Survey ◽  
Cross Sectional ◽  
Methylguanine Dna Methyltransferase ◽  
The Uk ◽  
To Receive

Abstract INTRODUCTION This study explored the relationship between MGMT testing and treatment patterns of patients with newly-diagnosed GBM from France, Germany, Italy, Spain, the UK (EU5), and Canada. MATERIALS AND METHODS Medical oncologists and neuro-oncologists across EU5 and Canada completed a point in time, cross-sectional survey for the next eight GBM patients seen between May and July 2016 (GBM Disease-specific ProgrammeTM). Statistically significant differences (p<0.05) between groups are presented. RESULTS A total of 241 physicians reported on 1,747 GBM patients. 1L patients had mean age 59.7 years (SD=12.3) and 36% were female. Of 1,113 (64%) patients who had an MGMT test performed with results recorded (tested), 58% (n=651) were methylated and 42% (n=462) were unmethylated. The remaining 634 patients (36%) were MGMT untested or awaiting MGMT results at time of survey (untested). Overall, 63% of patients received surgery prior to their 1L drug therapy, 78% received radiotherapy (RT; mean 4.3 sessions) in conjunction with 1L drug therapy, 90% received corticosteroids during RT, and 89% received temozolomide (TMZ). Patients who received corticosteroids during RT received similar drug treatments to those that did not, but were less likely to receive surgery prior to 1L treatment (65% vs 83%). MGMT-tested patients were more likely to receive surgery (66% vs 57%) and RT (81% vs 71%) than untested patients. Tested patients were also more likely to receive TMZ (92% vs 83%), and less likely to receive procarbazine+/lomustine+/vincristine (PCV; 3% vs 7%) or other chemotherapies (5% vs 11%). For 1L patients that experienced side effects, the most common effects included fatigue (74%), nausea (60%), and appetite loss (59%). Untested patients were more likely to stop their 1L drug treatment due to progression/recurrence of GBM (44% vs 36%). Patients who received surgery prior to 1L treatment were more likely to receive TMZ than those who did not (93% vs 82%). Among MGMT tested patients at 1L, methylated patients were more likely to receive RT (84% vs 78%) and TMZ (95% vs 89%) than unmethylated patients, and less likely to receive PCV (2% vs 5%) or other chemotherapy (4% vs 7%). Methylated patients with reported treatment-related side effects were less likely to experience dehydration (0% vs 10%), loss of strength/unusual weakness (5% vs 25%), memory problems (16% vs 35%), and nausea (51% vs 75%). CONCLUSIONS More than one-third of GBM patients in EU5 and Canada are not tested for MGMT-methylation. Untested patients are less likely to receive standard treatments than tested patients. Generally, TMZ is used in most patients regardless of MGMT testing and status. MGMT-methylated patients are more likely to receive standard treatments and experience fewer side effects than MGMT-unmethylated patients.

scholarly journals Healthcare Workers’ Willingness to Receive Influenza Vaccination in the Context of the COVID-19 Pandemic: A Survey in Southern Italy

Vaccines ◽  
2021 ◽  
Vol 9 (7) ◽  
pp. 766
Author(s):  
Gabriella Di Giuseppe ◽  
Concetta P. Pelullo ◽  
Andrea Paolantonio ◽  
Giorgia Della Polla ◽  
Maria Pavia
Keyword(s):  
Side Effects ◽  
Influenza Vaccine ◽  
Influenza Vaccination ◽  
Healthcare Workers ◽  
Southern Italy ◽  
Hospitalized Patients ◽  
Cross Sectional Survey ◽  
Enabling Factors ◽  
Cross Sectional ◽  
To Receive

This cross-sectional survey was designed to evaluate hospital healthcare workers’ (HCWs) willingness to receive the influenza vaccination during the COVID-19 pandemic and to identify the related determinants, since it is plausible that the two epidemics will coexist in future winters. Overall, 68% out of 490 participants expressed their willingness to receive influenza vaccination in the 2020/21 season, with 95% of those ever and 45.8% of those never vaccinated in the previous six influenza seasons. Belief that influenza vaccine is useful in distinguishing influenza symptoms from those of COVID-19 and that the influenza vaccine is useful to prevent influenza in hospital settings, willingness to receive COVID-19 vaccination, having no concern about influenza vaccine side effects, concern about the possibility to transmit influenza to hospitalized patients, and influenza vaccination in previous years were all predictors of willingness to receive influenza vaccination. In the context of the COVID-19 pandemic, a relevant increase in the willingness to undergo influenza vaccination was reported. Therefore, interventions focused primarily on enabling factors are needed to promote the adherence to influenza vaccination in future seasons among HCWs.

scholarly journals Assessment of Various Parameters of Dental Anxiety Among Nursing Students in Rural and Urban Area of Bareilly City India –A Cross Sectional Survey

2019 ◽  
Vol 21 (2) ◽  
pp. 95-99
Author(s):  
Karnika Yadav ◽  
N. Lakshminaryan
Keyword(s):  
Nursing Students ◽  
Urban Area ◽  
Dental Anxiety ◽  
Uttar Pradesh ◽  
Study Group ◽  
Cross Sectional Survey ◽  
Cross Sectional ◽  
Rural And Urban ◽  
Rural And Urban Area ◽  
To Receive

 To assess the various parameters of dental anxiety among nursing students in rural and urban area of Bareilly city India. A cross-sectional survey was conducted among nursing students aged 18 to 25 years in Bareilly city of Uttar Pradesh State in India. Dental anxiety was measured using Modified Dental Anxiety Scale (MDAS). It consists of three six-item scales that also use the Likert format. The data obtained were analysed using Analysis of variance (ANOVA). The study group individuals in majority were slightly anxious (59.4% and 47.5%) when questioned about their feelings on visit to dentist and sitting in dentist’s waiting area, while they would feel extremely anxious (29.9%) if they were to receive local anesthesia respectively. The conclusion drawn from the present study was that all are "slightly anxious" as compare to others.

scholarly journals Vaccine Acceptance and Hesitancy among College Students in Nevada: A State-Wide Cross-Sectional Study

Vaccines ◽  
2022 ◽  
Vol 10 (1) ◽  
pp. 105
Author(s):  
Leslie Elliott ◽  
Kanyeemengtiang Yang
Keyword(s):  
Native American ◽  
Side Effects ◽  
Health Information ◽  
Female Gender ◽  
Cross Sectional Study ◽  
Cross Sectional ◽  
Vaccine Acceptance ◽  
Public Health Agencies ◽  
Sources Of Health Information ◽  
To Receive

The purpose of this study was to identify factors related to COVID-19 vaccine acceptance and hesitancy in a diverse state-wide population of students. An electronic survey was emailed to students in the Nevada System of Higher Education to assess effects of the pandemic. The survey included questions related to vaccine status, interest in receiving the COVID-19 vaccine, factors influencing these decisions, and sources of health information. Among the 3773 respondents, over half (54%) were accepting of the vaccine, including vaccinated students (18.9%). Nearly one quarter (23.5%) expressed hesitancy to receive the vaccine, citing concerns about side effects and the need for more research. Factors related to hesitancy included female gender, increasing age, place of residence, marital status, and Black or Native American race. Vaccine hesitant respondents were less likely than other respondents to rely on public health agencies or newspapers for health information, and more likely to rely on employers, clinics, or “no one”. Culturally appropriate efforts involving COVID-19 vaccine information and distribution should target certain groups, focusing on factors such as side effects, development and testing of the vaccine. Research should investigate sources of health information of people who are hesitant to receive vaccines.

Acceptance and hesitancy to receive COVID-19 vaccine among university students in Egypt: a nationwide survey

2021 ◽  
Author(s):  
Samar Tharwat ◽  
Ahmed Mohammed Saad ◽  
Mohammed Kamal Nassar ◽  
Dalia Kamal Nassar
Keyword(s):  
University Students ◽  
Knowledge Score ◽  
Nationwide Survey ◽  
Vaccine Uptake ◽  
Survey Study ◽  
Vaccine Hesitancy ◽  
Cross Sectional Survey ◽  
Cross Sectional ◽  
Vaccine Acceptance ◽  
To Receive

Abstract Background: The public's willingness to be vaccinated will determine the success of the COVID-19 vaccination programme. The aim of this study was to identify acceptance and hesitancy to receive COVID-19 vaccine among university students in Egypt, assess their level of knowledge about COVID-19 vaccine and identify barriers for hesitancy to uptake of COVID-19 vaccine.Methods: This cross-sectional survey study included 1071 university students. A standardized and self-administered questionnaire was constructed by the authors and distributed to university students allover Egypt.Results: Of the 1071 respondents, 739 (69%) were willing to get vaccinated against COVID-19 while 223 (20.8%) reported vaccine hesitancy. Median knowledge score of participants about COVID-19 vaccine was 4 out of 8 (IQR=8). While fear of getting infected (53.6%) and desire to get back to normal life (51%) were the main motives for intention to get vaccinated, fear of serious side effects (100%) and doubting the efficacy of COVID-19 vaccine (60.5%) were the main reasons for vaccine hesitancy and resistance. About 21% of students (n=225) reported voluntary uptake of COVID-19 vaccine. Conclusion: We identified rates of COVID-19 vaccine acceptance and hesitancy and detected poor knowledge scores among university students which may hinder vaccine acceptance. We also detected poor translation of vaccination intention into actual vaccine uptake. Educational campaigns and efforts aiming to raise awareness about safety and efficacy of COVID-19 vaccines need to be directed to this important population.

scholarly journals COVID-19 Vaccine Hesitancy among the Public in Kuwait: A Cross-Sectional Survey

2021 ◽  
Vol 18 (16) ◽  
pp. 8836
Author(s):  
Jumana Alibrahim ◽  
Abdelmoneim Awad
Keyword(s):  
Family Members ◽  
Vaccine Uptake ◽  
Vaccine Hesitancy ◽  
Multivariable Logistic Regression Analysis ◽  
Snowball Sampling ◽  
Cross Sectional Survey ◽  
Cross Sectional ◽  
Major Barrier ◽  
The Public ◽  
To Receive

Vaccine hesitancy (uncertainty or unwillingness to receive vaccinations) is a major barrier to manage the COVID-19 pandemic in the long term. This study aimed to explore the prevalence of COVID-19 vaccine hesitancy among the public in Kuwait, to understand their attitudes towards vaccines in general, and to identify predictors of COVID-19 vaccine hesitancy. A cross-sectional study was conducted among 4147 adults aged ≥ 18 years. The snowball sampling strategy was used for data collection through social media and e-mails. A total of 3061 (73.8%) respondents indicated that they were vaccinated or intending to be vaccinated against the COVID-19 infection, while 1086 (26.2%) expressed their vaccine hesitancy. The most common reasons for vaccine hesitancy were the concerns about the vaccine’s possible side effects, its rushed development, and its efficacy in preventing the infection. Over half (57.2%) of respondents expressed intermediate to high levels of negative attitude towards vaccines in general. On the multivariable logistic regression analysis, the findings revealed that vaccine hesitancy was significantly more prevalent among respondents aged 30–64 years; females; married or divorced; residents of Hawalli, Al-Farwaniyah, Al-Jahra, and Mubarak Al-Kabeer; had intermediate monthly average income; non-smokers; not feeling worried about catching the infection; do not know whether any of their family members have been infected or died because of COVID-19 infection; do not have a large extent of confidence in the Kuwait health system’s ability to handle the pandemic; did not receive influenza vaccine during the last year; refused or elected to forego a doctor-recommended vaccine; did not receive adequate information from the public health authorities/healthcare providers about the COVID-19 vaccines; none of their first-degree family members received or were intending to receive the vaccine; and expressed intermediate to high levels of negative attitudes towards vaccines in general. The present findings provide a steer as to the groups that most need to be reached to increase the rates of vaccine uptake.

scholarly journals COVID-19 vaccine acceptance among high-risk populations in Uganda

2021 ◽  
Vol 8 ◽  
pp. 204993612110243
Author(s):  
Felix Bongomin ◽  
Ronald Olum ◽  
Irene Andia-Biraro ◽  
Frederick Nelson Nakwagala ◽  
Khalid Hudow Hassan ◽  
...  
Keyword(s):  
High Risk ◽  
Cross Sectional Survey ◽  
Cross Sectional ◽  
Vaccine Acceptance ◽  
History Of ◽  
High Risk Populations ◽  
Multivariable Analyses ◽  
To Receive ◽  
Vaccination Hesitancy ◽  
Structured Questionnaire

Background: Immunization is an important strategy for controlling the COVID-19 pandemic. COVID-19 vaccination was recently launched in Uganda, with prioritization to healthcare workers and high-risk individuals. In this study, we aimed to determine the acceptability of COVID-19 vaccine among persons at high risk of COVID-19 morbidity and mortality in Uganda. Methods: Between 29 March and 14 April 2021, we conducted a cross-sectional survey consecutively recruiting persons at high risk of severe COVID-19 (diabetes mellitus, HIV and cardiovascular disease) attending Kiruddu National Referral Hospital outpatient clinics. A trained research nurse administered a semi-structured questionnaire assessing demographics, COVID-19 vaccine related attitudes and acceptability. Descriptive statistics, bivariate and multivariable analyses were performed using STATA 16. Results: A total of 317 participants with a mean age 51.5 ± 14.1 years were recruited. Of this, 184 (60.5%) were female. Overall, 216 (70.1%) participants were willing to accept the COVID-19 vaccine. The odds of willingness to accept COVID-19 vaccination were four times greater if a participant was male compared with if a participant was female [adjusted odds ratio (AOR): 4.1, 95% confidence interval (CI): 1.8–9.4, p = 0.00]. Participants who agreed (AOR: 0.04, 95% CI: 0.01–0.38, p = 0.003) or strongly agreed (AOR: 0.04, 95% CI: 0.01–0.59, p = 0.005) that they have some immunity against COVID-19 were also significantly less likely to accept the vaccine. Participants who had a history of vaccination hesitancy for their children were also significantly less likely to accept the COVID-19 vaccine (AOR: 0.1, 95% CI: 0.01–0.58, p = 0.016). Conclusion: The willingness to receive a COVID-19 vaccine in this group of high-risk individuals was comparable to the global COVID-19 vaccine acceptance rate. Increased sensitization, myth busting and utilization of opinion leaders to encourage vaccine acceptability is recommended.

Sign in / Sign up

Export Citation Format

Share Document